Cost-control mechanisms in Canadian private drug plans

Healthcare Policy

Volumn 9, Issue 1, 2013, Pages 35-43

  Kratzer, Jillian ^a   McGrail, Kimberlyn ^a   Strumpf, Erin ^b   Law, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; DRUG COST; HUMAN; PRIVATE HEALTH INSURANCE; REIMBURSEMENT;

CANADA; COST ALLOCATION; COST CONTROL; DRUG COSTS; DRUGS, GENERIC; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; PRESCRIPTION DRUGS;

EID: 84883686550     PISSN: None     EISSN: 17156572     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Applied Management. 2000. Canadians? Access to Insurance for Prescription Medicines. Toronto: Applied Management in association with Fraser Group and Tristat Resources. Retrieved June 8, 2013. 〈http://www.frasergroup.com/ downloads/volume-2.pdf〉;
2. Blackburn, D.F., R.T. Dobson, J.L. Blackburn and T.W. Wilson. 2005. "Cardiovascular Morbidity Associated with Nonadherence to Statin Therapy." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25(8): 1035-43.
3. Blackwell, T. 2012 (September 10). "It's Generic Drugs or Nothing, Canadian Insurers Say." National Post. Retrieved June 9, 2013. 〈http://news.nationalpost.com/2012/09/10/its-generic-drugs-or-nothing- canadian-insurers-say〉.
4. Canadian Institute for Health Information (CIHI). 2012. Drug Expenditure in Canada, 1985 to 2011. Ottawa, ON.
5. Canadian Life and Health Insurance Association. 2012. "Backgrounder - Canadian Life and Health Insurance Industry Drug Pooling Agreement." Retrieved June 9, 2013. 〈http://www.clhia.ca/domino/html/clhia/CLHIA-LP4W- LND-Webstation.nsf/resources/Drug-Protection/file/backgrounder.pdf〉.
6. Daw, J.R. and S.G. Morgan. 2012. "Stitching the Gaps in the Canadian Public Drug Coverage Patchwork? A Review of Provincial Pharmacare Policy Changes from 2000 to 2010." Health Policy 104(1): 19-26.
7. Gagnon, M.A. 2010. The Economic Case for Universal Pharmacare. Ottawa: Canadian Centre for Policy Alternatives. Retrieved June 9, 2013. 〈http://www.policyalternatives.ca/sites/default/files/uploads/publications/ National%20Office/2010/09/Universal-Pharmacare.pdf〉.
8. Goldman, D. 2006. "Benefit Design and Specialty Drug Use." Health Affairs 25: 1319-31.
9. Goldman, D.P., G.F. Joyce and Y. Zheng. 2007. "Prescription Drug Cost Sharing: Associations with Medication and Medical Utilization and Spending and Health." Journal of the American Medical Association 298(1): 61-69.
10. Heisler, M., H. Choi, A.B. Rosen, S. Vijan, M. Kabeto, K.M. Langa and J.D. Piette. 2010. "Hospitalizations and Deaths among Adults with Cardiovascular Disease Who Underuse Medications Because of Cost." Medical Care 48(2): 87-94.
11. Kaiser Family Foundation. 2012. Employer Health Benefits - 2012 Annual Survey. Retrieved June 9, 2013. 〈http://ehbs.kff.org/pdf/2012/8345. pdf〉.
12. Kim, Y.A., K.L. Rascati, K. Prasla, P. Godley, N. Goel and D. Dunlop. 2011. "Retrospective Evaluation of the Impact of Copayment Increases for Specialty Medications on Adherence and Persistence in an Integrated Health Maintenance Organization System." Clinical Therapeutics 33(5): 598-607.
13. Mojtabai, R. and M. Olfson. 2003. "Medication Costs, Adherence and Health Outcomes among Medicare Beneficiaries." Health Affairs (Project Hope) 22(4): 220-29.
14. Morgan, S. and L. Yan. 2006. "Income-Based Drug Coverage in British Columbia: The Impact on Private and Public Expenditures." Healthcare Policy 2(2): 109-10.
15. Pomey, M.P., S. Morgan, J. Church, P.G. Forest, J.N. Lavis, T. McIntosh et al. 2010. "Do Provincial Drug Benefit Initiatives Create an Effective Policy Lab? The Evidence from Canada." Journal of Health Politics, Policy and Law 35(5): 705-42.
16. Rovere, M. and B. Bacchus. 2012. "Reforming the Ontario Drug Benefit Plan: A Missed Opportunity." Calgary: The Fraser Institute. Retrieved June 9, 2013. 〈http://www.fraserinstitute.org/uploadedFiles/fraser-ca/Content/ research-news/research/articles/reforming-the-ontario-drug-benefit-plan-ff0712. pdf〉.
17. Silversides, A. 2009. "Ontario's Law Curbing the Cost of Generic Drugs Sparks Changes." Canadian Medical Association Journal 181: 3-4. doi: 10.1503/cmaj.091155.
18. Tamblyn, R., R. Laprise, J.A. Hanley, M. Abrahamowicz, S. Scott, N. Mayo et al. 2001. "Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons." Journal of the American Medical Association 285(4): 421-29.
19. Telus Health. 2011. Average Dispensing Fees: July - December 2011. Retrieved June 9, 2013. 〈http://canadianemployeebenefitplans.ca/wp-content/ uploads/Dispensing-Fees-Jul-Dec-2011.pdf〉.
20. Woolhandler, S., T. Campbell and D.U. Himmelstein. 2003. "Costs of Health Care Administration in the United States and Canada." New England Journal of Medicine 349(8): 768-75.